Literature DB >> 1956128

Production of anti-platelet-activating factor antibodies by the use of colloidal gold as carrier.

A Tomii1, F Masugi.   

Abstract

Polyclonal and monoclonal antibodies to platelet-activating factor (PAF) were produced, by use of colloidal gold as the hapten carrier. These polyclonal (R88-09) and monoclonal (602 B11) antibodies both reacted with PAF, lysoplatelet-activating factor (lyso PAF), and L-alpha-lysophosphatidylcholine, palmitoyl (lyso PCP), but did not react with phosphorylcholine chloride (PCC). Their affinities were higher for PAF than lyso PAF and lyso PCP.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1956128     DOI： 10.7883/yoken1952.44.75

Source DB:  PubMed          Journal:  Jpn J Med Sci Biol        ISSN： 0021-5112


  4 in total

Review 1.  Nanoparticles and the immune system.

Authors:  Banu S Zolnik; Africa González-Fernández; Nakissa Sadrieh; Marina A Dobrovolskaia
Journal:  Endocrinology       Date:  2009-12-16       Impact factor: 4.736

2.  Current status of multiple antigen-presenting peptide vaccine systems: Application of organic and inorganic nanoparticles.

Authors:  Yoshio Fujita; Hiroaki Taguchi
Journal:  Chem Cent J       Date:  2011-08-23       Impact factor: 4.215

3.  Engineered metal based nanoparticles and innate immunity.

Authors:  Claudia Petrarca; Emanuela Clemente; Valentina Amato; Paola Pedata; Enrico Sabbioni; Giovanni Bernardini; Ivo Iavicoli; Sara Cortese; Qiao Niu; Takemi Otsuki; Roberto Paganelli; Mario Di Gioacchino
Journal:  Clin Mol Allergy       Date:  2015-07-15

4.  Immunological properties of gold nanoparticles.

Authors:  Lev A Dykman; Nikolai G Khlebtsov
Journal:  Chem Sci       Date:  2016-11-16       Impact factor: 9.825
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.